Event programme
ETPN2026 at a glance

Detailed time schedule
Wednesday, June 17
Day 1
Day 1
Arrival & check-in
Badge collection and arrival for the opening morning of ETPN2026.
Activity & financial reports
The statutory opening block of the General Assembly, focused on core reporting and essential member information in a concise and structured format.
Venue: Desmond Auditorium
View details
This part of the General Assembly is reserved for ETPN members.
Building a Nanomedicine Story
Choices, risks and lessons learned with Laurent Lévy, followed by a short scientific talk on mRNA-LNP engineering of human T cells.
Venue: Houston Lecture Theatre
Explore the session
The ETPN Academy is a dedicated morning format for PhD students, early-stage researchers and young professionals, built to give participants direct access to senior leaders, entrepreneurs and technology experts in a more informal and practical format than a standard scientific session.
In this first session, Laurent Lévy will share lessons from the development of a nanomedicine company and reflect on the scientific, strategic, entrepreneurial and clinical choices that shape the translation of an advanced technology towards patients.
The session will also include a short 20-minute scientific contribution by Sergio Garrido Areal on non-viral engineering of human T cells using immunomodulatory mRNA lipid nanoparticles.
Members’ interactive forum
A shorter, discussion-oriented member block designed to keep the General Assembly useful, focused and genuinely member-facing.
Venue: Desmond Auditorium
View details
This part of the General Assembly is reserved for ETPN members.
Practical Technology Insights
Formulation, particle analysis and characterisation with Inside Therapeutics, SPARTA Biodiscovery and Postnova Analytics.
Venue: Houston Lecture Theatre
View contributors and topics
The second Academy session gives participants direct access to three ETPN sponsors and industry members through short, practical and didactic contributions. The format remains informal, interactive and educational, with a strong focus on practical understanding rather than commercial presentation.
ETPN2026 Poster Symposium
The event opens to all attendees with a dedicated poster-focused block designed to trigger early interaction, visibility and scientific exchange across the community.
View details
Posters will receive dedicated visibility during this session, in addition to standard networking and break moments.
LabPlan sponsor highlight
A brief sponsor talk by Dr Alfonso Blanco, focused on CytoFLEX Nano and extracellular particle analysis.
View LabPlan sponsor highlight
Welcome + FP10 / Policy Strategic Opening
A strategic opening discussion to connect ETPN2026 with the future European research and innovation framework, and to frame how nanomedicine, advanced materials and HealthTech can remain visible, clinically relevant and translation-ready in FP10.
Meet the opening contributors
The first keynote of ETPN2026 closes Day 1 with a fundamental and forward-looking perspective on how nanostructures interact with living systems, and what this may unlock for advanced therapeutics.
Discover Kenneth Dawson’s keynote
Professor Kenneth A. Dawson is Director of the Centre for BioNano Interactions (CBNI) at University College Dublin. His scientific work focuses on understanding how nanostructures interact with living systems, and he pioneered the biomolecular, or protein, corona concept, which became a central paradigm in the field.
His research aims to obtain a mechanistic and molecular understanding of nanoscale recognition in biology. His most recent work explores how fundamental insights at the nanoscale interface may help enable escape from endosomes and reach therapeutically inaccessible locations.
Thursday, June 18
Day 2
Day 2
Clinical Needs / Unmet Clinical Needs in Nanomedicine
This moderated panel will bring clinical perspectives into direct discussion with the nanomedicine and health technology community. Contributors will highlight real unmet needs, patient relevance, clinical adoption challenges and the practical conditions required for advanced technologies to become genuinely useful in care.
Explore this clinical-needs panel
Nano-enabled Medical Devices, Diagnostics & Clinical Decision Support
A core scientific session focused on the interface between nanomedicine, diagnostics, devices and clinically actionable technologies, with strong translational and implementation relevance.
View speaker & talk line-up
Dr Paul Galvin is Senior Head of Groups for Bioelectronics, Head of the Life Sciences Interface Group, Head of ICT for Health Strategic Programmes and Director of the ENTIRE European Digital Innovation Hub at Tyndall National Institute in Cork, Ireland. Working with clinical scientists and the digital healthtech industry, he has led multidisciplinary national and international digital healthtech research projects leveraging deep tech, nano and semiconductor-enabled solutions to address diagnostic and therapeutic challenges in healthcare.
SENSOPAD
A concise EU project spotlight integrated after the DEVICES session, highlighting the SENSOPAD project and its approach to portable sensing for endometriosis.
View project spotlight
Scale-up, Manufacturing, Regulation & Translational Complexity
One of the structural sessions of ETPN2026, this block addresses the real bottlenecks that often determine whether promising nanomedicine innovation can actually reach patients.
View speaker & talk line-up
Olivia Lewis is a PhD candidate in Drug Regulatory Science at Utrecht University and part of the NANOSPRESSO-NL project. Her research focuses on regulatory challenges related to nucleic acid therapeutics, lipid-based nanoparticle delivery systems and decentralised manufacturing approaches for personalised medicines. Her work connects regulatory science, translational medicine and the societal implementation of innovative therapies.
SPARTA Biodiscovery sponsor highlight
A brief sponsor talk by Dr Ben Peacock, focused on single-particle Raman spectroscopy for complex nanomedicines and LNP analytics.
View SPARTA Biodiscovery sponsor highlight
SPARTA enables high-resolution, single-particle analysis of lipid nanoparticles, revealing structural and compositional variability across batches to inform design, manufacturing and targeting strategies.
Pitch Me Up!
A dynamic, innovation-oriented format designed to give visibility to translational projects, emerging companies and innovation-driven initiatives with strong application potential.
View pitch presentations
This session is intended to be punchier and more entrepreneurial in rhythm, while remaining fully aligned with the scientific and translational identity of the event.
The second keynote of ETPN2026 will bring a high-level scientific and translational perspective on nucleic acid nanomedicines, RNA/LNP therapeutics, delivery design and the evolving path from platform development to clinical impact.
Explore Raymond Schiffelers’ keynote
Professor Raymond Schiffelers is Professor of Nanomedicine at the University Medical Center Utrecht, where his work focuses on synthetic drug delivery systems, RNA delivery and extracellular vesicles as inspiration for new therapeutic and diagnostic approaches. Trained in Bio-Pharmaceutical Sciences at Leiden University, he obtained his PhD at Erasmus University Rotterdam on liposomal targeting of antimicrobial agents, before working on liposome- and polymer-based delivery systems for tumour vasculature targeting and siRNA delivery in Utrecht and in the US. He has contributed extensively to the development of nanomedicine platforms for diagnosis and therapy, has co-founded and advised several start-ups, and served as Chair of the European Technology Platform on Nanomedicine from 2021 to 2025.
Friday, June 19
Day 3
Day 3
European Projects in Nanomedicine
The final day opens with a compact European-facing block giving visibility to current collaborative initiatives, project dynamics and concrete examples of nanomedicine activity across Europe.
View project talks
This session is designed to keep a strong European and coordination-oriented tone at the start of Day 3.
Upcoming Funding Opportunities for Nanomedicine
A compact brokerage session to support new European collaborations, project ideas and upcoming funding opportunities in nanomedicine and related health technologies.
Explore this session
Regenerative Medicine & Advanced Therapeutic Interfaces
This scientific block highlights regenerative approaches, advanced interfaces and next-generation therapeutic concepts at the boundary of nanomedicine and broader HealthTech innovation.
View speaker & talk line-up
Professor Fergal O’Brien is Deputy Vice Chancellor for Research and Innovation, Professor of Bioengineering and Regenerative Medicine, and Head of the Tissue Engineering Research Group at RCSI. He is a leading innovator in advanced biomaterials and medical devices for tissue repair, with particular interest in scaffold-based delivery of nanomedicines for enhanced regeneration. His work spans publications, patents, doctoral supervision, spin-out activity and clinical translation of regenerative technologies.
Emerging Therapies, Precision Nanomedicine & Advanced Drug Delivery
The final flagship therapeutic session of ETPN2026 closes the scientific programme with a forward-looking focus on advanced delivery strategies, precision approaches and emerging therapeutic modalities.
View speaker & talk line-up
Sergio Moya studied Chemistry at the University of the South, Argentina, and obtained his PhD while working at the Max Planck Institute of Colloids and Interfaces, Germany. He subsequently carried out postdoctoral research at the Collège de France and the University of Cambridge. Since 2007, he has been a group leader at CIC biomaGUNE, Spain. His research interests span physical chemistry, materials science and nanomedicine.
Awards + Best Talks & Best Posters + Closing Remarks
The event concludes with final recognition moments, including the Best Talks and Best Posters awards sponsored by SSPC, closing remarks and a short wrap-up designed to end the meeting with clarity, appreciation and momentum for what comes next.
View details
Awards and closing remarks, including Best Talks and Best Posters recognition sponsored by SSPC, and final wrap-up of ETPN2026.
Registration
ETPN2026 is open to all: students, researchers, engineers, clinicians, SMEs, industry, institutions. Join us in Dublin next June and seize the opportunity to connect with pioneers in nanomedicine and MedTech, enriching your professional network and knowledge. Dive into interactive sessions designed to spark innovation and collaboration in the vibrant field of nanomedicine, advanced materials & emerging healthtech.
Subscribe for updates
Join the ETPN2026 community and stay updated on the conference. Subscribe for exclusive news and insights that keep you ahead. Don’t miss your chance to connect with innovators and explore new opportunities in healthcare.
ETPN2026 Dublin | 21st Annual Event of ETPN
ETPN2026 Dublin is the 21st Annual Event of the European Technology Platform on Nanomedicine, hosted by RCSI in Dublin from 17 to 19 June 2026. A lean, fully in-person edition focused on science, translation, collaboration and community building
Contact
contact@etpn2026.eu
ETPN Association
64-66 rue des archives 75003 Paris, FRANCE
© 2026 ETPN2026. All rights reserved.
